These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15254443)

  • 21. Update: prophylaxis for HIV opportunistic infections.
    Murphy MJ
    Fac Notes (New Orleans La); 1998; 10(1):5-6. PubMed ID: 11365025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: Updated Guidelines from the Centers for Disease Control and Prevention, National Institutes of Health, and HIV Medicine Association of the Infectious Diseases Society of America.
    Masur H; Brooks JT; Benson CA; Holmes KK; Pau AK; Kaplan JE; ; ;
    Clin Infect Dis; 2014 May; 58(9):1308-11. PubMed ID: 24585567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
    Pozio E
    Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recommendations on prophylaxis and therapy for disseminated Mycobacterium avium complex for adults and adolescents infected with human immunodeficiency virus. U.S. Public Health Service Task Force on Prophylaxis and Therapy for Mycobacterium avium Complex.
    MMWR Recomm Rep; 1993 Jun; 42(RR-9):14-20. PubMed ID: 8393134
    [No Abstract]   [Full Text] [Related]  

  • 25. 1999 USPHS/IDSA Guidelines for the Prevention of Opportunistic Infections in Persons Infected with HIV: Part II. Prevention of the first episode of disease. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention. U.S. Public Health Service/Infectious Diseases Society of America.
    Am Fam Physician; 2000 Jan; 61(2):441-2, 445-9, 453-4 passim. PubMed ID: 10670509
    [No Abstract]   [Full Text] [Related]  

  • 26. USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: a summary.
    Ann Intern Med; 1996 Feb; 124(3):349-68. PubMed ID: 8554235
    [No Abstract]   [Full Text] [Related]  

  • 27. 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. U.S. Public Health Service (USPHS) and Infectious Diseases Society of America (IDSA).
    MMWR Recomm Rep; 1999 Aug; 48(RR-10):1-59, 61-6. PubMed ID: 10499670
    [No Abstract]   [Full Text] [Related]  

  • 28. Preaching what we practice: new guidelines for OI prophylaxis.
    Feinberg J
    AIDS Clin Care; 1999 Nov; 11(11):87-9, 94. PubMed ID: 11366709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disseminated mycobacterium avium-intracellulare complex (MAC) infection in the era of effective antiretroviral therapy: is prophylaxis still indicated?
    Lange CG; Woolley IJ; Brodt RH
    Drugs; 2004; 64(7):679-92. PubMed ID: 15025543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What's new in the 2009 US guidelines for prevention and treatment of opportunistic infections among adults and adolescents with HIV?
    Brooks JT; Kaplan JE; Masur H
    Top HIV Med; 2009; 17(3):109-14. PubMed ID: 19675369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [GESIDA/National AIDS Plan: Consensus document on antiretroviral therapy in adults infected by the human immunodeficiency virus (Updated January 2015)].
    Panel de expertos de GeSIDA y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2015 Oct; 33(8):543.e1-43. PubMed ID: 25959461
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Preventing opportunistic infections in patients infected with the human immunodeficiency virus].
    Rev Panam Salud Publica; 2001 Aug; 10(2):125-38. PubMed ID: 11575240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 2001 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus.
    ; ;
    HIV Clin Trials; 2001; 2(6):493-554. PubMed ID: 11742438
    [No Abstract]   [Full Text] [Related]  

  • 34. Preventive services guidelines for primary care clinicians caring for adults and adolescents infected with the human immunodeficiency virus.
    Gerber AR; Valdiserri RO; Holtgrave DR; Jones TS; West GR; Hinman AR; Curran JW
    Arch Fam Med; 1993 Sep; 2(9):969-79. PubMed ID: 8111528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of opportunistic infections in the era of improved antiretroviral therapy.
    Chaisson RE; Moore RD
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997; 16 Suppl 1():S14-22. PubMed ID: 9389311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [CBO guidelines 'Antiretroviral therapy in the Netherlands'].
    Borleffs JC; Danner SA; Lange JM; van Everdingen JJ;
    Ned Tijdschr Geneeskd; 2001 Aug; 145(33):1585-9. PubMed ID: 11534375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Introduction to the 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus.
    Masur H; Holmes KK; Kaplan JE
    Clin Infect Dis; 2000 Apr; 30 Suppl 1():S1-4. PubMed ID: 10770910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. U.S. Public Health Service/Infectious Diseases Society of America (USPHS/IDSA) guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: a summary.
    Pediatr AIDS HIV Infect; 1995 Dec; 6(6):372-96. PubMed ID: 11361464
    [No Abstract]   [Full Text] [Related]  

  • 39. USPHS and IDSA collaborate on guidelines to prevent opportunistic infections in HIV-infected persons.
    Kaplan JE; Holmes KK
    Emerg Infect Dis; 1995; 1(3):102-3. PubMed ID: 8903176
    [No Abstract]   [Full Text] [Related]  

  • 40. The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis.
    Nachman S; Gona P; Dankner W; Weinberg A; Yogev R; Gershon A; Rathore M; Read JS; Huang S; Elgie C; Hudgens K; Hughes W
    Pediatrics; 2005 Apr; 115(4):e488-94. PubMed ID: 15772172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.